Clinical Trials Logo

Filter by:
NCT ID: NCT06090825 Recruiting - Pancreatic Cancer Clinical Trials

Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient

Start date: September 1, 2023
Phase:
Study type: Observational

It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors from the General Surgery Department in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland.

NCT ID: NCT06090812 Completed - Acute Brain Injury Clinical Trials

Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis

Start date: January 1, 2021
Phase:
Study type: Observational

In this study, we investigated the clinical variability in paroxysmal sympathetic hyperactivity in patients with acute brain injury and examined the prognostic value of the Paroxysmal Sympathetic Hyperactivity Assessment Measure (PSH-AM) in relation to Doppler ultrasound assessment of volume status, right heart function, and pulmonary edema. Thirty patients with ABI were prospectively enrolled. A correlation analysis between the PSH-AM score and related clinical indicators was performed using Pearson's or Spearman's correlation coefficient. Receiver operating characteristic curves were used to assess the prediction of the 6-month Glasgow Outcome Scale Extended score for neurorehabilitation prognosis.

NCT ID: NCT06090799 Recruiting - Clinical trials for Prevention of Graft Rejection After Organ Transplantation

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Start date: November 29, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, double-blind, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-3032 in healthy adults.

NCT ID: NCT06090773 Completed - Acute Kidney Injury Clinical Trials

Characteristics of Renal Blood Flow in AKI Patients in ICU and Its Clinical Significance

Start date: June 1, 2023
Phase:
Study type: Observational

To study the changes in the renal artery and renal vein with renal cortical and medullary microcirculatory blood flow in patients with sepsis; to study the relationship between renal arteriolar and renal vein with renal cortical and medullary microcirculatory blood flow and renal function; and to find the value of ultrasonographic assessment of renal blood flow indices for evaluating prognosis in patients with sepsis.

NCT ID: NCT06090682 Recruiting - Parkinson Disease Clinical Trials

Effect and Mechanism of Brain Stimulation for Parkinson's Disease With Cognitive Impairment

Start date: November 1, 2023
Phase:
Study type: Observational

This study intends to apply structural and functional brain network neuroimaging techniques combined with image post-processing methods to explore the differences in brain network changes in PD patients with cognitive impairment after DBS or TMS.

NCT ID: NCT06090656 Recruiting - Clinical trials for Hepatocellular Carcinoma

Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)

BEST
Start date: October 24, 2023
Phase: Phase 2
Study type: Interventional

Transcatheter arterial chemoembolization (TACE) is recommended as the standard of care for patients with intermediate-stage hepatocellular carcinoma (HCC) (i.e., BCLC stage B). However, these patients is heterogeneous in terms of liver functional, tumor size and tumor number, and not all patients with mid-stage HCC will benefit from TACE. The ORIENT-32 trial confirmed the efficacy of sintilimab in combination with bevacizumab for unresectable hepatocellular carcinoma. No study has yet explored whether this regimen is appropriate for patients with BCLC stage B. The purpose of this study is to explore whether bevacizumab in combination with sintilimab is superior to conventional TACE therapy in patients with HCC with beyond-Up-to-seven criteria.

NCT ID: NCT06090136 Completed - Clinical trials for Erectile Dysfunction

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

Start date: September 14, 2020
Phase: Phase 1
Study type: Interventional

It is a single-center, open-label, Phase I clinical study evaluating the safety and pharmacokinetics of a single oral TPN171H in elderly subjects.

NCT ID: NCT06090123 Completed - Clinical trials for Erectile Dysfunction

Drug-Drug Interaction (DDI) Study for TPN171H

Start date: January 1, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of this study was to assess the effect of rifampicin,a cytochrome P450 3A4 enzyme (CYP3A4) induction, on the pharmacokinetics (PK) of TPN171H in chinese healthy male subjects ,and assess the effect of itraconazole,cytochrome P450 3A4 enzyme (CYP3A4) induction on the PK of TPN171H in chinese healthy male subjects

NCT ID: NCT06089733 Enrolling by invitation - Healthy Subjects Clinical Trials

A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021

Start date: April 11, 2023
Phase: Phase 1
Study type: Interventional

This study is a single center, open lable and fixed sequence test conducted in healthy subjects to evaluate the pharmacokinetic effects of Itraconazole and Rifampicin on a single dose of ABSK021 Oral administration. It is planned to enroll 32 healthy subjects and assign them to two parallel test groups, Part A (ABSK021 combined with Itraconazole) and Part B (ABSK021 combined with Rifampicin).

NCT ID: NCT06089395 Not yet recruiting - Clinical trials for Poor Ovarian Response

The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)

Start date: June 1, 2024
Phase: Early Phase 1
Study type: Interventional

Relying on the Department of Gynecology of Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine and chaoyang hospital of Capital medical university, this randomized controlled clinical study was carried out to investigate the application of kidney tonifying herbs to patients with poor ovarian response(POR). A total of 76 patients with POR were collected and stratified district groups were randomly divided into a test group and a control group, with 38 patients included in each group. The experimental group was intervented with JJGS granules + coenzyme Q10 simulant, and the control group was intervened with coenzyme Q10 + JJGS granules simulant. AMH, serum basal sex hormone, AFC, TCM syndrome score, modified Kupperman scale and pregnancy status were observed before and after treatment to investigate the effects of Jiajian Guishen granules on the ovarian function of POR patients.